phentolamine has been researched along with Coronary Artery Disease in 5 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fractional flow reserve (FFR, calculated by coronary pressure measurements during adenosine-induced hyperaemia) was assessed in 85 patients with an intermediate coronary stenosis (mean diameter stenosis of 50+/-1%) and normal left ventricular function which were divided into the following three groups: (a) 33 patients before and after IC bolus of phentolamine, an alpha1-, alpha2-adrenergic blocker; (b) 32 patients before and after IC bolus of urapidil, a selective alpha1-adrenergic blocker; (c) 20 patients before and after IC bolus of saline." | 3.72 | Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. ( Aarnoudse, W; Barbato, E; Bartunek, J; De Bruyne, B; Heyndrickx, GR; Pijls, NH; Staelens, F; Vanderheyden, M; Wijns, W, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbato, E | 2 |
| Bartunek, J | 2 |
| Aarnoudse, W | 1 |
| Vanderheyden, M | 1 |
| Staelens, F | 1 |
| Wijns, W | 2 |
| Heyndrickx, GR | 1 |
| Pijls, NH | 1 |
| De Bruyne, B | 2 |
| Piscione, F | 2 |
| Galasso, G | 1 |
| Cirillo, P | 1 |
| De Luca, G | 1 |
| Iaccarino, G | 1 |
| Chiariello, M | 2 |
| van de Wal, RM | 1 |
| van der Harst, P | 1 |
| Wagenaar, LJ | 1 |
| Wassmann, S | 1 |
| Morshuis, WJ | 1 |
| Nickenig, G | 1 |
| Buikema, H | 1 |
| Plokker, HW | 1 |
| van Veldhuisen, DJ | 1 |
| van Gilst, WH | 1 |
| Voors, AA | 1 |
| Indolfi, C | 1 |
| Russolillo, E | 1 |
| Villari, B | 1 |
| Golino, P | 1 |
| Ambrosini, V | 1 |
| Condorelli, M | 1 |
| Evans, GL | 1 |
| Smulyan, H | 1 |
| Eich, RH | 1 |
5 other studies available for phentolamine and Coronary Artery Disease
| Article | Year |
|---|---|
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Coronar | 2004 |
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
Topics: Acetylcholine; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Albutero | 2005 |
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiote | 2007 |
Digoxin-induced vasoconstriction of normal and atherosclerotic epicardial coronary arteries.
Topics: Angiography, Digital Subtraction; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; D | 1991 |
Role of peripheral resistance in the control of cardiac output.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Corona | 1967 |